Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors
IntroductionNeuroendocrine neoplasms including neuroendocrine tumors (NETs) are often diagnosed as primary disseminated or inoperable. In those cases, systemic extensive therapy is necessary, but radical treatment is unlikely. As described in the literature, in some selected cases, peptide receptor...
Enregistré dans:
Auteurs principaux: | Marta Opalińska, Anna Sowa-Staszczak, Anna Grochowska, Helena Olearska, Alicja Hubalewska-Dydejczyk |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/1254a0f6a8cc42f8becf30fad0bed1c7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Clinical Approach to Neuroendocrine Neoplasm Associated With Ovarian Teratoma
par: Marta Opalińska, et autres
Publié: (2021) -
A Novel Strategy for the Diagnosis of Pulmonary High-Grade Neuroendocrine Tumor
par: Kentaro Miura, et autres
Publié: (2021) -
Imaging of Neuroendocrine Prostatic Carcinoma
par: Ahmed Taher, et autres
Publié: (2021) -
Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours
par: Marianne S. Elston, et autres
Publié: (2021) -
Prevalence of Neuroendocrine Tumors in the Gastrointestinal and Hepatobiliary Systems
par: Modesto J Varas Lorenzo, et autres
Publié: (2019)